26 July 2020: Clinical Research
Is Noninvasive Prenatal Screening Appropriate for Pregnant Women Age 35 or Older In Cases if Isolated Fetal Nasal Bone Abnormalities in The Chinese Han Population?
Yuan Chen 1ACDEF* , Min Lv 1ABEF* , Tian Dong 1BC , Qinqing Chen 1BC , Yeqing Qian 2AD , Baihui Zhao 1ADFG , Qiong Luo 1ADEFG*DOI: 10.12659/MSM.924387
Med Sci Monit 2020; 26:e924387
Table 3 Cost-effectiveness ratio of two screening strategies in pregnant women older than 35.
| strategies | Costs (USD) | Effectiveness (CA detected) | Cost per CA detected (USD) |
|---|---|---|---|
| Contingent screening strategy | 63143.74 | 8 | 7893.86 |
| Invasive diagnostic test | 170999.41 | 8 | 21377.34 |
| CA – chomosomal abnormalities. The costs were calculated based on pregnant women older than 35(n=394). The cost of invasive diagnostic test was calculated as karyotyping or CMA. | |||